Home
       
STOCK MARKETS


Back

10 Last viewed shares   
 
Year in Brief
  Year in Brief
  REVENUE The consolidated revenue of the Group for the year 2018 amounted to approximately RMB 740,422,000, comparing to approximately RMB 497,694,000 for the ...
  Read more... 
Company Presentation
  Company Presentation
  Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in ...
  Read more... 
Strategy & Goals
  Strategy & Goals
  Corporate Strategy Össur’s vision is to be the leading company in non-invasive orthopaedics. Össur’s business is improving people’s mobility through ...
  Read more... 
   

Evotec SE

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer

SHARE DATA GRAPH TECHNICAL ANALYSIS
Select class of Share
Evotec (FRK)‎  
Last 8,90      Change % 0,00 
Add to Portfolio
Add to Watchlist
Add to Alerts

10 LAST TRADES EUR
Time Last Volume
Displayed time is based on the time zone of your choice on Euroland.com
Refresh
ChartImage
 
QUOTES EUR
Time 2024-07-15
Last 8,90
Change % 0,00 
Change 0,00 
Bid/Ask 8,87 / 8,91
Open 9,03
High/Low 9,03 / 8,84
Volume 0
Previous Close 8,90
52 Weeks High 24,45
52 Weeks Low 7,30
52 Weeks %   -60,24 
YTD %   -58,28 
Volatility 86,24
Beta 1,06
Correlation 0,33
MARKET DATA
Symbol EVT
Market  Frankfurt
List  Prime Standard
Domestic Industry  Pharmaceutical & Healthcare
Euroland-Industry  Biotechnology
Shares (mil)1 177,55
Market Cap (mil) 1 579,34
1 - Number of shares in specific class of share. Otherwise it is total number of shares issued.

INDICES
 MDAX
 Technology All Share
 HDAX
 TecDAX
 Prime All Share
 

Data delayed at least 15 minutes. From Hanoi & HoChiMinh data is real time. From Milan, Dublin & Tokyo data is as end of day.
Data provided by vwd group Switzerland AG & MOEX.

 
 
   Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024